These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
656 related articles for article (PubMed ID: 11920888)
1. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. Souter VL; Nyberg DA; El-Bastawissi A; Zebelman A; Luthhardt F; Luthy DA Prenat Diagn; 2002 Mar; 22(3):175-82. PubMed ID: 11920888 [TBL] [Abstract][Full Text] [Related]
2. Correlation of second-trimester sonographic and biochemical markers. Souter VL; Nyberg DA; Benn PA; Zebelman A; Luthardt F; Luthy DA J Ultrasound Med; 2004 Apr; 23(4):505-11. PubMed ID: 15098869 [TBL] [Abstract][Full Text] [Related]
5. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
7. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization. McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771 [TBL] [Abstract][Full Text] [Related]
8. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
9. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes]. Hu Z; Liu X; Li L; Jia C; Li D; Liu R Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246 [TBL] [Abstract][Full Text] [Related]
10. Cystic hygroma and mid-trimester maternal serum screening. Celentano C; Prefumo F; Iezzi I; Guanciali-Franchi PE; Palka C; Liberati M; Rotmensch S J Med Screen; 2007; 14(3):109-12. PubMed ID: 17925081 [TBL] [Abstract][Full Text] [Related]
11. Extreme second-trimester serum analyte values in down syndrome pregnancies with hydrops fetalis. Benn PA; Egan JF; Ingardia CJ J Matern Fetal Neonatal Med; 2002 Apr; 11(4):262-5. PubMed ID: 12375682 [TBL] [Abstract][Full Text] [Related]
12. First- and second-trimester screening: detection of aneuploidies other than Down syndrome. Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME; Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613 [TBL] [Abstract][Full Text] [Related]
13. Society for Maternal-Fetal Medicine Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester: (Replaces Consults #10, Single umbilical artery, October 2010; #16, Isolated echogenic bowel diagnosed on second-trimester ultrasound, August 2011; #17, Evaluation and management of isolated renal pelviectasis on second-trimester ultrasound, December 2011; #25, Isolated fetal choroid plexus cysts, April 2013; #27, Isolated echogenic intracardiac focus, August 2013). ; Prabhu M; Kuller JA; Biggio JR Am J Obstet Gynecol; 2021 Oct; 225(4):B2-B15. PubMed ID: 34171388 [TBL] [Abstract][Full Text] [Related]
14. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome. Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586 [TBL] [Abstract][Full Text] [Related]
15. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects. Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ Prenat Diagn; 2009 Jun; 29(6):570-7. PubMed ID: 19266536 [TBL] [Abstract][Full Text] [Related]
16. Using second trimester ultrasound and maternal serum biomarker data to help detect congenital heart defects in pregnancies with positive triple-marker screening results. Jelliffe-Pawlowski LL; Walton-Haynes L; Currier RJ Am J Med Genet A; 2008 Oct; 146A(19):2455-67. PubMed ID: 18785270 [TBL] [Abstract][Full Text] [Related]
17. [Investigation of ultrasound markers in screening fetal trisomy 21]. Shi XM; Fang Q; Chen BJ; Xie HN; Xie YJ; Chen JH; Wu JZ Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):81-5. PubMed ID: 23544486 [TBL] [Abstract][Full Text] [Related]
18. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Cicero S; Bindra R; Rembouskos G; Spencer K; Nicolaides KH Prenat Diagn; 2003 Apr; 23(4):306-10. PubMed ID: 12673635 [TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD; McIntosh SF; Halstead AC Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [TBL] [Abstract][Full Text] [Related]